Elizabeth K. Bisaccia
YOU?
Author Swipe
View article: Implementation Strategies for Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action) to Prevent Neonatal Medication-Induced Kidney Injury
Implementation Strategies for Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action) to Prevent Neonatal Medication-Induced Kidney Injury Open
Acute kidney injury (AKI) is a common complication among patients admitted to the neonatal intensive care unit. Nephrotoxic medications (NTMs) are known to increase the incidence of AKI, but the use of these medications is often unavoidab…
View article: Children's Oncology Group's 2023 blueprint for research: Pharmacy
Children's Oncology Group's 2023 blueprint for research: Pharmacy Open
Children's Oncology Group (COG) pharmacists and pharmacy technicians from more than 200 COG‐member institutions comprise the COG Pharmacy Discipline. Discipline members serve an essential role in the design and execution of COG clinical tr…
View article: Nusinersen: A Novel Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy
Nusinersen: A Novel Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy Open
Spinal muscular atrophy (SMA) encompasses a group of autosomal recessively inherited degenerative neuromuscular disorders. They range in severity from neonatal onset with rapidly progressive weakness and early mortality (SMA-1), to onset i…